Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Four SPACs Tap Markets for $530 Million Total (Law360)

Related Content

Antitrust & Competition Healthcare Quarterly Update Q1 2025

1x1 with Matthew Renfro at Lynx

Health Headlines: April 2025

Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare

Five Trends Reshaping Pharmaceutical Manufacturing Partnerships

1x1 With Dr. Marla Dubinsky at Trellus Health

Health Headlines: March 2025

States Continue to Pursue and Expand Healthcare Market Oversight at an Unprecedented Pace, With Significant Implications for Private Equity

Health Data Regulation in Focus As 2025 State Legislative Session Comes to a Close (PLI Plus)

AI in Healthcare: Private Equity’s Next Frontier? (Real Deals)

Healthcare M&A and Financing in 2025 (HealthcareMarkets)

Goodwin Is Top Law Firm for Global M&A for Q1 2025

Goodwin Grows Private Equity Practice With New SF Partner (Law360)

Goodwin’s Annual Healthcare & Life Sciences Summit

Goodwin Leads M&A, Private Equity, and Venture Capital League Table Rankings for 2024

PE Implications of Recent Revisions to Massachusetts' Healthcare Transaction Review Law

Healthcare

Life Sciences

Private Equity

Technology

Special Purpose Acquisition Companies (SPACs)